NL
DE
17 March 2020
“It is especially important for people with Parkinson’s to have the best vision possible because it can help compensate for movement problems caused by the disease, and help reduce the risk of falls,” said study author Carlijn D.J.M. Borm, M.D., of Radboud University Medical Centre in Nijmegen, The Netherlands. “Our study found not only that people with Parkinson’s disease had eye problems that go beyond the aging process, we also found those problems may interfere with their daily lives. Yet a majority of eye problems are treatable, so it’s important that people with Parkinson’s be screened and treated if possible.”
The study involved 848 people with Parkinson’s who had symptoms for an average of seven years. They were compared to 250 people without the disease. Both groups had an average age of 70.
Participants completed a questionnaire about vision and eye problems. For each problem described, such as “I have a burning sensation or gritty feeling in my eyes” and “Lines that should be straight appear to be wavy or blurred,” participants were asked to choose from a range of four responses. A response of “never have symptoms” was worth one point. A response of “daily symptoms” was worth four points. There were 16 such questions as well as one question about visual hallucinations that required a yes or no response, with yes being worth one point, for a total possible score of 51 points.
Participants were also asked if eye problems interfered with their daily activities such as driving a car, working on a computer, walking or personal care.
Researchers found that 82% of people with Parkinson’s reported one or more eye problems compared to 48% of people without the disease. The average score on the questionnaire was 10 points for people with Parkinson’s compared to two points for people without the disease. Researchers also found that eye problems interfered with daily life for 68% of people with Parkinson’s compared to 35% of people without the disease.
“Eye problems make it more difficult for people with Parkinson’s to physically navigate daily life, for example we found that half of study participants experienced problems with reading, and 33% had eye problems that interfered with driving a car,” said Borm. “People with Parkinson’s who express that they have eye problems should be referred to a specialist for further evaluation. For those who do not express such problems, using a questionnaire to screen for problems that may otherwise be missed might allow for recognition, timely treatment, and improving the quality of life.”
A limitation of the study was that since people were asked if they would like to participate in the study, it is possible that people with vision problems were more likely to respond, possibly resulting in an overestimation of eye problems.
The study was supported by the Stichting Parkinson Fonds.
“It is especially important for people with Parkinson’s to have the best vision possible because it can help compensate for movement problems caused by the disease, and help reduce the risk of falls,” said study author Carlijn D.J.M. Borm, M.D., of Radboud University Medical Centre in Nijmegen, The Netherlands. “Our study found not only that people with Parkinson’s disease had eye problems that go beyond the aging process, we also found those problems may interfere with their daily lives. Yet a majority of eye problems are treatable, so it’s important that people with Parkinson’s be screened and treated if possible.”
The study involved 848 people with Parkinson’s who had symptoms for an average of seven years. They were compared to 250 people without the disease. Both groups had an average age of 70.
Participants completed a questionnaire about vision and eye problems. For each problem described, such as “I have a burning sensation or gritty feeling in my eyes” and “Lines that should be straight appear to be wavy or blurred,” participants were asked to choose from a range of four responses. A response of “never have symptoms” was worth one point. A response of “daily symptoms” was worth four points. There were 16 such questions as well as one question about visual hallucinations that required a yes or no response, with yes being worth one point, for a total possible score of 51 points.
Participants were also asked if eye problems interfered with their daily activities such as driving a car, working on a computer, walking or personal care.
Researchers found that 82% of people with Parkinson’s reported one or more eye problems compared to 48% of people without the disease. The average score on the questionnaire was 10 points for people with Parkinson’s compared to two points for people without the disease. Researchers also found that eye problems interfered with daily life for 68% of people with Parkinson’s compared to 35% of people without the disease.
“Eye problems make it more difficult for people with Parkinson’s to physically navigate daily life, for example we found that half of study participants experienced problems with reading, and 33% had eye problems that interfered with driving a car,” said Borm. “People with Parkinson’s who express that they have eye problems should be referred to a specialist for further evaluation. For those who do not express such problems, using a questionnaire to screen for problems that may otherwise be missed might allow for recognition, timely treatment, and improving the quality of life.”
A limitation of the study was that since people were asked if they would like to participate in the study, it is possible that people with vision problems were more likely to respond, possibly resulting in an overestimation of eye problems.
The study was supported by the Stichting Parkinson Fonds.
Related news items
Five million euro’s for joint research on rare movement disorders
29 March 2022 A Dutch consortium will receive almost 5 million euro’s from NWO to jointly start an ambitious project, called CureQ, on various rare and genetic brain disorders that lead to abnormal movements. Bart van de Warrenburg was one of the main applicants of this ‘Nationale Wetenschaps Agenda (NWA)’ grant. read more
Development of RNA therapy for rare movement disorder SCA7 Brain Foundation grant for Radboudumc and LUMC
3 February 2022 Neurologist Bart van de Warrenburg, together with Willeke van Roon-Mom and Annemieke Aartsma-Rus (both LUMC/Dutch Center for RNA Therapeutics), has been awarded 400,000 euros by the Dutch Brain Foundation to develop a genetic therapy for the rare hereditary movement disorder SCA7. read more
Aerobe exercise has a positive effect on brain function in Parkinson's disease patients
18 January 2022 Radboudumc researchers have shown that the brain function of patients with Parkinson's disease improved with regular exercise, which seems to strengthen the connections between different brain areas, while inhibiting brain shrinkage. read more
New genetic defect links cell biology and protein glycosylation
10 November 2021 Peter Linders, Dirk Lefeber and Geert van den Bogaart together with international colleagues have recently reported on novel cell biological insights, by identifying a genetic disorder in syntaxin-5 which allowed to unravel a new mechanism regulating intracellular transportation. read more
Impact of COVID-19 pandemic on mental health of Parkinson's patients
10 November 2021 The COVID-19 pandemic has introduced challenges to the social life and care of people with Parkinson’s disease (PD), which could potentially worsen mental health problems. A new study investigated this associaten and explored whether mental health and quality of life can be improved. read more